Altamira Therapeutics Ltd
CYTO
CYTO was delisted on the 19th of December, 2024.
3 hedge funds and large institutions have $497K invested in Altamira Therapeutics Ltd in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
6% less capital invested
Capital invested by funds: $531K → $497K (-$34K)
40% less funds holding
Funds holding: 5 → 3 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$122K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$54K |
| 2 |
Morgan Stanley
New York
|
-$35.4K |
| 3 |
WS
Wedbush Securities
Los Angeles,
California
|
-$35K |
| 4 |
Jane Street
New York
|
-$30K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $461K | +$122K | +110 | +36% |
|
|
2
Morgan Stanley
New York
| $34K | -$35.4K | -32 | -51% |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | +$2.21K | +2 | New |
|
|
VF
4
Virtu Financial
New York
| – | -$54K | -49 | Closed |
|
|
WS
5
Wedbush Securities
Los Angeles,
California
| – | -$35K | -31 | Closed |
|
|
6
Jane Street
New York
| – | -$30K | -27 | Closed |
|
CYTO Hedge Fund Activity: Q3 2019 in Review
3 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2019, worth a combined $497K — down 6.4% from $531K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CYTO and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Sabby Management, adding an estimated $122K. The largest seller was Virtu Financial, exiting entirely with an estimated $54K sold.
- 3 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2019, down from 5 in Q2 2019.
- Funds reported $497K of Altamira Therapeutics Ltd stock for Q3 2019, down 6.4% quarter-over-quarter.
- 1 fund opened new Altamira Therapeutics Ltd positions in Q3 2019 and 3 closed out, a net change of -2 holders.
- The largest Altamira Therapeutics Ltd buyer in Q3 2019 was Sabby Management, an estimated $122K added.
- The largest Altamira Therapeutics Ltd seller in Q3 2019 was Virtu Financial, an estimated $54K sold.
Based on aggregated 13F filings for Q3 2019.